statistiche ricercatore

VISCA, DINA

Distribuzione geografica

Continente	#
NA - Nord America	4.474
EU - Europa	2.224
AS - Asia	345
SA - Sud America	22
OC - Oceania	8
AF - Africa	6
Continente sconosciuto - Info sul continente non disponibili	6
Totale	7.085

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	4.464
IT - Italia	1.392
UA - Ucraina	284
IE - Irlanda	194
VN - Vietnam	172
SE - Svezia	146
DE - Germania	71
GB - Regno Unito	68
TR - Turchia	66
CN - Cina	63
AT - Austria	15
FI - Finlandia	15
JP - Giappone	11
CL - Cile	10
BR - Brasile	9
CA - Canada	9
ES - Italia	8
AU - Australia	7
IR - Iran	7
RO - Romania	7
IN - India	6
EU - Europa	5
AE - Emirati Arabi Uniti	4
NL - Olanda	4
SA - Arabia Saudita	4
AR - Argentina	3
FR - Francia	3
MD - Moldavia	3
MY - Malesia	3
SG - Singapore	3
AL - Albania	2
BD - Bangladesh	2
CH - Svizzera	2
RU - Federazione Russa	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
DK - Danimarca	1
EG - Egitto	1
GR - Grecia	1
HK - Hong Kong	1
HU - Ungheria	1
KZ - Kazakistan	1
LK - Sri Lanka	1
LY - Libia	1
MU - Mauritius	1
MX - Messico	1
MZ - Mozambico	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PL - Polonia	1
PT - Portogallo	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
UG - Uganda	1
ZM - Zambia	1
Totale	7.085

Salva come PNG Salva come JPEG

Città	#
Milan	1.004
Fairfield	746
Ashburn	450
Woodbridge	351
Chandler	337
Houston	302
Seattle	283
Wilmington	281
Cambridge	278
Jacksonville	269
Dublin	188
Princeton	182
Ann Arbor	134
Nyköping	99
Dearborn	93
Dong Ket	89
Rome	89
San Diego	74
New York	73
Izmir	62
Ogden	45
London	26
Redmond	21
San Genesio Ed Uniti	19
Como	17
Washington	17
Vienna	15
Norwalk	14
Kunming	11
Hefei	10
Helsinki	10
Pavia	9
Beijing	8
Kilburn	8
Magnago	8
Toronto	8
São Paulo	7
Tokyo	7
Redwood City	6
San Francisco	6
Chicago	5
Chiswick	5
Guangzhou	5
Nanjing	5
Varese	5
Lappeenranta	4
Los Angeles	4
Prescot	4
Treviglio	4
Amsterdam	3
Bergamo	3
Chennai	3
Chisinau	3
Dubai	3
Hangzhou	3
Kuala Lumpur	3
Lünen	3
Nanchang	3
New Bedfont	3
Riyadh	3
San Mateo	3
Bilbao	2
Bresso	2
Brisbane	2
Buffalo	2
Cividate al Piano	2
Dallas	2
Dhaka	2
Edinburgh	2
Esslingen am Neckar	2
Frankfurt am Main	2
Gazoldo degli Ippoliti	2
Genoa	2
Madrid	2
Misterbianco	2
Paris	2
Pune	2
San Jose	2
Shenyang	2
Singapore	2
Acton	1
Almaty	1
Andover	1
Auckland	1
Bari	1
Berlin	1
Bilgi	1
Boardman	1
Budapest	1
Buenos Aires	1
Cairo	1
Changsha	1
Chaoyang	1
Chengdu	1
Clearwater	1
Colombo	1
Eden Prairie	1
Florence	1
Greenwich	1
Gubbio	1
Totale	5.791

Salva come PNG Salva come JPEG

Nome	#
Classifying new anti-tuberculosis drugs: rationale and future perspectives	177
When kidneys and lungs suffer together	160
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	158
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	158
Intestine: Organ or Apparatus?	141
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	140
Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation.	138
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial	136
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	134
Is bronchodilator the correct treatment for COPD subjects before EBUS?	131
Cardiovascular function in pulmonary emphysema	129
Tuberculosis elimination: Where are we now?	126
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD	125
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial	125
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases	125
Ambulatory oxygen in interstitial lung disease	122
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: A systematic review	121
Classification of Malabsorption Syndromes	121
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery	121
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis	120
Adverse Reactions to Food: Allergies and Intolerances	119
Ventilatory response to carbon dioxide output in subjects with congestive heart failure and in patients with COPD with comparable exercise capacity	117
Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico	114
Relationship between diabetes and respiratory diseases—Clinical and therapeutic aspects	114
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis	113
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases	112
World TB Day 2017: Strengthening the fight against TB	110
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis	110
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: a global feasibility study	110
Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night	109
Fecal calprotectin concentrations in alcoholic patients	108
Evolution of programmatic definitions used intuberculosis prevention and care	105
Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler	99
Multi and extensively drug-resistant pulmonary tuberculosis: Advances in diagnosis and management	83
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine	81
The role of blood gas analysis in the post-acute phase of COVID-19 pneumonia	81
Care-Related intervention in Rehabilitative Pneumology: Pulmonary Rehabilitation in Chronic Obstructive Broncopneumopathies (COPD) can benefit from a multidisciplinary approach? [Cure correlate in Pneumologia Riabilitativa: La Riabilitazione Polmonare nelle Broncopneumopatie Croniche Ostruttive (BPCO) può trarre beneficio da un approccio multidisciplinare?]	80
Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns	80
Pulmonary Rehabilitation and Asthma	79
Minimal clinically important difference of the 6-min walking test in patients with asthma	77
The 5-Repetition Sit-to-Stand Test as an Outcome Measure for Pulmonary Rehabilitation in Subjects With Asthma	76
Is Two Better Than One? The Impact of Doubling Training Volume in Severe COPD: A Randomized Controlled Study	75
Electrocardiographic features of patients with COVID-19 pneumonia	74
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network	69
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report	68
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact	68
Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients	68
Severity of COVID-19: The importance of being hypertensive	66
Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. Authors' reply	66
A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries	62
SARS-CoV-2 vaccines: Lights and shadows	59
Effectiveness of a Pulmonary Rehabilitation Program on Persistent Asthma Stratified for Severity	57
Post-TB disease: a new topic for investigation-and why it matters	55
Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial	54
Pulmonary Rehabilitation in Patients Recovering from COVID-19	53
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations	53
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression	52
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts	51
Tuberculosis and COVID-19 co-infection: description of the global cohort	51
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort	50
Chronic cough in adults	48
Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients	48
Combined use of electrocardiography and ultrasound to detect cardiac and pulmonary involvement after recovery from COVID-19 pneumonia: A case series	48
Pulmonary rehabilitation: Promising nonpharmacological approach for treating asthma?	47
Pulmonary rehabilitation in patients with interstitial lung diseases: Correlates of success	47
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment	47
Post tuberculosis treatment infectious complications	46
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease	45
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)	45
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease	43
High-flow oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease and chronic hypoxemia: A multicenter randomized controlled trial	43
Tuberculosis in the time of COVID-19: quality of life and digital innovation	42
Something is changing in adherence to CPAP therapy: Real world data after 1 year of treatment in patients with obstructive sleep apnoea	41
Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients	41
Epidemic and pandemic viral infections: Impact on tuberculosis and the lung	41
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial	41
Correction to: When kidneys and lungs suffer together (Journal of Nephrology, (2019), 32, 5, (699-707), 10.1007/s40620-018-00563-1)	40
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects	38
Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry	38
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life	37
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease	37
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment	36
Analysis of Patients with Asthma and Mixed Granulocytic Inflammatory Pattern in Sputum	35
Severe asthma: One disease and multiple definitions	33
Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts	33
Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study	32
Post-tuberculosis sequelae: The need to look beyond treatment Outcome	32
The need for pulmonary rehabilitation following tuberculosis treatment	31
Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence	31
Post-tuberculosis (TB) treatment: The role of surgery and rehabilitation	30
Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19	30
Management of chronic refractory cough in adults	29
Current developments and future directions in COPD	28
The Maugeri daily activity profile: A tool to assess physical activity in patients with chronic obstructive pulmonary disease	28
Impact of COVID-19 on patients with asthma	27
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis	26
TB and COVID-19 co-infection: Rationale and aims of a global study	24
Time course of exercise capacity in patients recovering from covid-19-associated pneumonia	23
History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis	19
Effect of pulmonary rehabilitation on heart rate recovery in adult individuals with asthma or chronic obstructive pulmonary disease	12
Totale	7.378

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	35.338
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	35.338

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	380	0	0	0	0	0	0	0	0	0	57	156	167
2019/2020	1.170	48	67	66	240	91	121	158	130	102	63	23	61
2020/2021	1.910	88	85	148	148	180	105	78	157	303	132	195	291
2021/2022	970	147	27	64	11	33	63	85	72	58	244	69	97
2022/2023	1.055	102	82	104	132	58	227	6	109	133	49	21	32
2023/2024	1.773	248	259	245	301	374	154	72	18	75	27	0	0
Totale													7.413